Company now holds 12 U.S. patents.
Dyadic International Inc., Jupiter, Fla., says it has been issued U.S. Patent No. 8,304,212, titled “Methods and compositions for degradation of lignocellulosic material” by the United States Patent and Trademark Office (USPTO).
Dyadic, which bills itself as “a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical and industrial enzyme industries,” says the inventions embodied by the patent “relate to methods and compositions for using enzyme mixtures to convert plant biomass into fermentable sugars for the production of useful products.”
“In developing and selling industrial enzymes, our customers and partners not only benefit from Dyadic’s patented C1 platform technology, but also from Dyadic’s fungal strains and technologies based on the Trichoderma fungal organism,” says Dyadic President and CEO Mark Emalfarb. “Dyadic uses these strains to produce specialty enzymes that can be used for a variety of applications in such fields as animal health and nutrition, biofuels and bio-based chemicals.”
The patent also describes methods of increasing the yield of fermentable sugars from fermentation of distillers’ dried grains (DDGs), says the company in a news release. DDGs can be a byproduct of ethanol production that can entail using enzymes to in both biofuels and animal feed applications.
The newly issued patent is accessible on the USPTO’s website at www.uspto.gov or on Dyadic’s website at www.dyadic.com.